| Primary |
| Hypertension |
58.6% |
| Blood Pressure Abnormal |
9.1% |
| Diabetes Mellitus |
3.4% |
| Cardiac Disorder |
3.1% |
| Blood Cholesterol Increased |
2.8% |
| Blood Pressure |
2.8% |
| Pain |
2.8% |
| Gastrooesophageal Reflux Disease |
2.5% |
| Atrioventricular Block |
1.7% |
| Raynaud's Phenomenon |
1.7% |
| Angina Pectoris |
1.4% |
| Anxiety |
1.4% |
| Glaucoma |
1.4% |
| Myocardial Infarction |
1.4% |
| Pulmonary Arterial Hypertension |
1.1% |
| Type 2 Diabetes Mellitus |
1.1% |
| Depression |
0.8% |
| Dyspnoea |
0.8% |
| Fluid Retention |
0.8% |
| Heart Rate Irregular |
0.8% |
|
| Drug Ineffective |
13.1% |
| Blood Pressure Inadequately Controlled |
7.7% |
| Death |
7.7% |
| Blood Pressure Increased |
6.9% |
| Malaise |
6.9% |
| Medication Residue |
5.4% |
| Cardiac Disorder |
4.6% |
| Hypertension |
4.6% |
| Nausea |
4.6% |
| Headache |
3.8% |
| Hypersensitivity |
3.8% |
| Oedema Peripheral |
3.8% |
| Somnolence |
3.8% |
| Weight Decreased |
3.8% |
| Wrong Technique In Drug Usage Process |
3.8% |
| Asthenia |
3.1% |
| Cerebrovascular Accident |
3.1% |
| Hypotension |
3.1% |
| Joint Swelling |
3.1% |
| Palpitations |
3.1% |
|
| Secondary |
| Hypertension |
31.3% |
| Drug Use For Unknown Indication |
16.6% |
| Product Used For Unknown Indication |
6.0% |
| Blood Pressure Abnormal |
4.6% |
| Diabetes Mellitus |
4.1% |
| Blood Cholesterol Increased |
3.9% |
| Cardiac Disorder |
3.9% |
| Raynaud's Phenomenon |
3.7% |
| Pain |
3.2% |
| Blood Pressure |
2.8% |
| Cardiovascular Disorder |
2.8% |
| Chest Pain |
2.5% |
| Gastrooesophageal Reflux Disease |
2.5% |
| Angina Pectoris |
2.1% |
| Atrioventricular Block |
1.8% |
| Liver Transplant |
1.8% |
| Neuropathy Peripheral |
1.8% |
| Pulmonary Arterial Hypertension |
1.8% |
| Antidepressant Therapy |
1.4% |
| Back Pain |
1.4% |
|
| Asthma |
7.3% |
| Death |
7.3% |
| Drug Ineffective |
7.3% |
| Weight Decreased |
6.4% |
| Cerebrovascular Accident |
5.5% |
| Hypertension |
5.5% |
| Somnolence |
5.5% |
| Tooth Loss |
5.5% |
| Vomiting |
5.5% |
| Blood Pressure Decreased |
4.6% |
| Cardiac Disorder |
4.6% |
| Hypoacusis |
4.6% |
| Urinary Tract Infection |
4.6% |
| Weight Fluctuation |
4.6% |
| Dizziness |
3.7% |
| Medication Residue |
3.7% |
| Vascular Graft |
3.7% |
| Vision Blurred |
3.7% |
| Weight Increased |
3.7% |
| Abdominal Discomfort |
2.8% |
|
| Concomitant |
| Drug Use For Unknown Indication |
22.9% |
| Product Used For Unknown Indication |
20.8% |
| Hypertension |
15.5% |
| Nuclear Magnetic Resonance Imaging |
4.2% |
| Pain |
4.2% |
| Multiple Myeloma |
4.0% |
| Migraine |
3.0% |
| Depression |
2.8% |
| Rheumatoid Arthritis |
2.6% |
| Insomnia |
2.5% |
| Anxiety |
2.2% |
| Blood Pressure |
2.1% |
| Fistulogram |
2.0% |
| Pulmonary Arterial Hypertension |
1.8% |
| Blood Cholesterol Increased |
1.7% |
| Diabetes Mellitus |
1.7% |
| Hypothyroidism |
1.7% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Thyroid Cancer Metastatic |
1.4% |
| Arthritis |
1.3% |
|
| Vomiting |
17.8% |
| Weight Decreased |
8.2% |
| Skin Tightness |
7.5% |
| Respiratory Failure |
7.1% |
| Urinary Tract Infection |
5.3% |
| Weight Increased |
5.3% |
| Pain |
5.0% |
| Death |
4.3% |
| Ventricular Tachycardia |
3.9% |
| Visual Disturbance |
3.9% |
| Pneumonia |
3.6% |
| Tremor |
3.6% |
| Wheezing |
3.6% |
| Myocardial Infarction |
3.2% |
| Nervousness |
3.2% |
| Pulmonary Embolism |
3.2% |
| Drug Ineffective |
2.8% |
| Migraine |
2.8% |
| Nephrogenic Systemic Fibrosis |
2.8% |
| Oedema Peripheral |
2.8% |
|
